Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Troy Wilson is listed as Chief Executive Officer at Kura Oncology, Inc., based in United States, United States, United States. AeroLeads shows a matched LinkedIn profile for Troy Wilson.
Troy Wilson previously worked as President and Chief Executive Officer at Kura Oncology, Inc. and Executive Chairman of the Board of Directors at Wellspring Biosciences. Troy Wilson holds J.D., Law from New York University School Of Law.
This section adds company-level context without repeating Troy Wilson's masked contact details.
Review company-level records connected to Troy Wilson before choosing the right outreach path.
http://about.me/troyewilsonTroy E. Wilson, Ph.D., J.D., is one of Kura’s co-founders and has served as our President and Chief Executive Officer and as the chairman of our Board of Directors since our inception in August 2014. Previously, Dr. Wilson served as President and Chief Executive Officer of Wellspring Biosciences, Inc., a privately-held biopharmaceutical company, and its parent company Araxes Pharma LLC from July 2012 to March 2019 and as President and Chief Executive Officer of Avidity Biosciences LLC, a privately-held biopharmaceutical company, from November 2012 to February 2019. Dr. Wilson served as the President and Chief Executive Officer and a member of the Board of Directors of Intellikine, Inc., a privately-held biopharmaceutical company, from April 2007 to January 2012 and from August 2007 to January 2012, respectively, until its acquisition by Takeda Pharmaceutical Company Limited. He has also been a member of the board of directors of Puma Biotechnology, Inc., a publicly-held biopharmaceutical company, since October 2013, Executive Chairman and a member of the board of directors of Avidity Biosciences, Inc. since February 2019 and November 2012, respectively, Executive Chairman and a member of the board of directors of Wellspring Biosciences since February 2019 and July 2012, respectively, and a member of the board of managers of Araxes Pharma LLC since July 2012. Dr. Wilson holds a J.D. from New York University and graduated with a Ph.D. in bioorganic chemistry and a B.A. in biophysics from the University of California, Berkeley.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
San Diego, California, US
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company’s pipeline consists of small molecule drug candidates that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients.
Wellspring and its parent company, Araxes Pharma, are closely held and committed to creating breakthrough medicines for the treatment of cancer and other serious diseases. The companies were founded by Yi Liu, Ph.D., Pingda Ren, Ph.D., Kevan Shokat, Ph.D. and Troy Wilson, Ph.D., J.D., based upon pioneering research into KRAS G12C inhibitors conducted by.
Wellspring and its parent company, Araxes Pharma, are closely held and committed to creating breakthrough medicines for the treatment of cancer and other serious diseases. The companies were founded by Yi Liu, Ph.D., Pingda Ren, Ph.D., Kevan Shokat, Ph.D. and Troy Wilson, Ph.D., J.D., based upon pioneering research into KRAS G12C inhibitors conducted by.
San Diego, California, US
Avidity Biosciences is a privately held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.
San Diego, California, US
Avidity Biosciences is a privately held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.
Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those.
Intellikine was a leading private company focused on the development of innovative, small molecule drugs targeting the PI3K/mTOR pathway for the treatment of cancer and other serious diseases. Founded in September 2007, Intellikine raised $41 million from a group of leading investors, including Sofinnova Ventures, CMEA Capital, Novartis Venture Funds.
San Diego, California, US
Wildcat Discovery Technologies accelerates the discovery of new materials for energy applications, with a focus on the development of advanced materials for rechargeable and primary batteries. Wildcat’s business also includes collaborative development projects for materials for other applications, including gas storage, carbon capture, thermoelectrics, and.
San Diego, CA, US
Ambrx®, Inc. was a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics using an expanded genetic code. Unlike conventional conjugation techniques that create a mixture of suboptimal molecules, Ambrx technology combines site specific conjugation with proprietary linkers, payloads and pharmacokinetic extenders to create a.
Quick answers generated from the profile data available on this page.
Troy Wilson works for Kura Oncology, Inc..
Troy Wilson is listed as Chief Executive Officer at Kura Oncology, Inc..
Troy Wilson is based in United States, United States, United States while working with Kura Oncology, Inc..
Troy Wilson has worked for Kura Oncology, Inc., Wellspring Biosciences, Avidity Biosciences, Inc., Puma Biotechnology, and Intellikine.
You can use AeroLeads to view verified contact signals for Troy Wilson at Kura Oncology, Inc., including work email, phone, and LinkedIn data when available.
Troy Wilson holds J.D., Law from New York University School Of Law.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts